Brief: Anavex Life Sciences Regains Compliance With Nasdaq Periodic Filing Requirement
02/09/2026 21:08
BRIEF-Anavex Life Sciences Regains Compliance With Nasdaq Periodic Filing Requirement Sept 2 (Reuters) - Anavex Life Sciences Corp AVXL.O:
ANAVEX LIFE SCIENCES REGAINS COMPLIANCE WITH NASDAQ PERIODIC FILING REQUIREMENT
Source text: ID:nGNX3HlDlq
Further company coverage: AVXL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board